| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |